FACS analyses revealed that U266 cells express the highest levels of syndecan-1 (Figure 2C, upper panel), as would be expected for myeloma cells, whereas U87 cells express high levels of syndecan-4 (Figure 2C, lower panel). Here, SDC4 is linked to plasma cell myeloma.